BI-6C9
|
B343462-50mg
|
Moligand™, ≥95% |
791835-21-7 |
50mg
|
¥ 3309.9
|
期货,请咨询 |
阿拉丁 |
BI-6C9
|
B343462-25mg
|
Moligand™, ≥95% |
791835-21-7 |
25mg
|
¥ 2319.9
|
期货,请咨询 |
阿拉丁 |
BI-6C9
|
B343462-10mg
|
Moligand™, ≥95% |
791835-21-7 |
10mg
|
¥ 1179.9
|
期货,请咨询 |
阿拉丁 |
BI-6C9
|
B343462-100mg
|
Moligand™, ≥95% |
791835-21-7 |
100mg
|
¥ 4509.9
|
期货,请咨询 |
阿拉丁 |
联苯胺
|
B305975-500g
|
≥95% |
92-87-5 |
500g
|
¥ 9999.9
|
期货,请咨询 |
阿拉丁 |
6-甲氧基-1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚
|
B301171-5g
|
≥95% |
20315-68-8 |
5g
|
¥ 1149.9
|
期货,请咨询 |
阿拉丁 |
6-甲氧基-1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚
|
B301171-250mg
|
≥95% |
20315-68-8 |
250mg
|
¥ 69.9
|
期货,请咨询 |
阿拉丁 |
6-甲氧基-1,2,3,4-四氢-9H-吡啶并[3,4-b]吲哚
|
B301171-1g
|
≥95% |
20315-68-8 |
1g
|
¥ 257.9
|
期货,请咨询 |
阿拉丁 |
BML-267,蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂
|
B276014-50mg
|
≥95% |
N/A |
50mg
|
¥ 4399.9
|
期货,请咨询 |
阿拉丁 |
BML-267,蛋白酪氨酸磷酸酶1B(PTP1B)抑制剂
|
B276014-100mg
|
≥95% |
N/A |
100mg
|
¥ 6999.9
|
期货,请咨询 |
阿拉丁 |
芸苔甾醇
|
B136332-1mg
|
≥97% |
474-67-9 |
1mg
|
¥ 749.9
|
期货,请咨询 |
阿拉丁 |
芸苔甾醇
|
B136332-10mg
|
≥97% |
474-67-9 |
10mg
|
¥ 2899.9
|
期货,请咨询 |
阿拉丁 |
(+)-冰片
|
B119291-25g
|
Moligand™, ≥98% |
464-43-7 |
25g
|
¥ 1129.9
|
期货,请咨询 |
阿拉丁 |
2-氨基-6-甲氧基苯并噻唑
|
A758912-50g
|
≥95% |
1747-60-0 |
50g
|
¥ 45.9
|
期货,请咨询 |
阿拉丁 |
2-氨基-6-甲氧基苯并噻唑
|
A758912-100g
|
≥95% |
1747-60-0 |
100g
|
¥ 72.9
|
期货,请咨询 |
阿拉丁 |
冰乙酸
|
A758682-500ml
|
≥99% |
64-19-7 |
500ml
|
¥ 46.9
|
期货,请咨询 |
阿拉丁 |
冰乙酸
|
A758682-100ml
|
≥99% |
64-19-7 |
100ml
|
¥ 29.9
|
现货 |
阿拉丁 |
2-氨基苯磺酸
|
A758599-500g
|
≥96% |
88-21-1 |
500g
|
¥ 132.9
|
期货,请咨询 |
阿拉丁 |
2-氨基苯磺酸
|
A758599-25g
|
≥96% |
88-21-1 |
25g
|
¥ 29.9
|
期货,请咨询 |
阿拉丁 |
2-氨基苯磺酸
|
A758599-100g
|
≥96% |
88-21-1 |
100g
|
¥ 42.9
|
期货,请咨询 |
阿拉丁 |
氨水
|
A758569-500ml
|
22.0-24.0% NH3 basis |
1336-21-6 |
500ml
|
¥ 86.9
|
期货,请咨询 |
阿拉丁 |
氨水
|
A758569-100ml
|
22.0-24.0% NH3 basis |
1336-21-6 |
100ml
|
¥ 39.9
|
期货,请咨询 |
阿拉丁 |
4-(6-(丙烯酰氧基)己氧基)苯甲酸
|
A758391-5g
|
≥96% |
83883-26-5 |
5g
|
¥ 92.9
|
期货,请咨询 |
阿拉丁 |
4-(6-(丙烯酰氧基)己氧基)苯甲酸
|
A758391-1g
|
≥96% |
83883-26-5 |
1g
|
¥ 53.9
|
期货,请咨询 |
阿拉丁 |